NYSE:NEUE NeueHealth (NEUE) Stock Price, News & Analysis → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free neue Stock Alerts $6.07 0.00 (0.00%) (As of 02:30 PM ET) Add Compare Share Share Today's Range$5.67▼$6.2350-Day Range$5.82▼$10.1052-Week Range$4.94▼$26.95Volume23,395 shsAverage Volume28,429 shsMarket Capitalization$49.90 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get NeueHealth alerts: Email Address NeueHealth MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside32.2% Upside$8.00 Price TargetShort InterestHealthy0.26% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.15Based on 22 Articles This WeekInsider TradingSelling Shares$232,967 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.92 out of 5 starsMedical Sector1305th out of 2,771 stocksHospital & Medical Service Plans Industry20th out of 31 stocks 3.0 Analyst's Opinion Consensus RatingNeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageNeueHealth has only been the subject of 1 research reports in the past 90 days.Read more about NeueHealth's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.26% of the outstanding shares of NeueHealth have been sold short.Short Interest Ratio / Days to CoverNeueHealth has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeueHealth has recently decreased by 49.53%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldNeueHealth does not currently pay a dividend.Dividend GrowthNeueHealth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NEUE. Previous Next 2.3 News and Social Media Coverage News SentimentNeueHealth has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 22 news articles for NeueHealth this week, compared to 3 articles on an average week.MarketBeat Follows3 people have added NeueHealth to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $232,967.00 in company stock.Percentage Held by Insiders64.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about NeueHealth's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of NeueHealth is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeueHealth is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about NeueHealth's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTII’ve got a question for you…There’s no need to stare at boring charts all day long… These moves ALWAYS start in the same hour of the day…Click here because I need to hear from you About NeueHealth Stock (NYSE:NEUE)NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.Read More NEUE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NEUE Stock News HeadlinesMay 14 at 1:28 AM | americanbankingnews.comFinancial Survey: NeueHealth (NEUE) & Its PeersMay 13 at 1:20 AM | americanbankingnews.comContrasting NeueHealth (NEUE) and Its CompetitorsMay 12 at 1:50 AM | americanbankingnews.comNeueHealth (NEUE) vs. Its Peers Financial AnalysisMay 12 at 1:16 AM | americanbankingnews.comHead-To-Head Survey: NeueHealth (NYSE:NEUE) and Alignment Healthcare (NASDAQ:ALHC)May 11 at 10:53 AM | msn.comNeueHealth, Inc. (NYSE:NEUE) Q1 2024 Earnings Call TranscriptMay 11 at 1:36 AM | americanbankingnews.comHead to Head Analysis: NeueHealth (NYSE:NEUE) & Oscar Health (NYSE:OSCR)May 10, 2024 | americanbankingnews.comFinancial Survey: NeueHealth (NEUE) versus Its RivalsMay 10, 2024 | americanbankingnews.comComparing Alignment Healthcare (NASDAQ:ALHC) and NeueHealth (NYSE:NEUE)May 9, 2024 | finance.yahoo.comQ1 2024 NeueHealth Inc Earnings CallMay 9, 2024 | finance.yahoo.comNeueHealth Inc (NEUE) (Q1 2024) Earnings Call Transcript Highlights: Insights and Strategic ...May 9, 2024 | americanbankingnews.comHead-To-Head Survey: NeueHealth (NEUE) and Its RivalsMay 9, 2024 | americanbankingnews.comComparing NeueHealth (NEUE) and Its CompetitorsMay 9, 2024 | americanbankingnews.comNeueHealth (NEUE) and Its Competitors Critical AnalysisMay 8, 2024 | markets.businessinsider.comNeueHealth Q1 Revenue DropsMay 8, 2024 | msn.comNeueHealth GAAP EPS of -$2.31, revenue of $245.09MMay 8, 2024 | washingtonpost.comNeueHealth: Q1 Earnings SnapshotMay 8, 2024 | businesswire.comNeueHealth Reports First Quarter 2024 ResultsMay 7, 2024 | americanbankingnews.comNeueHealth (NEUE) versus Its Rivals Head to Head ContrastMay 7, 2024 | americanbankingnews.comComparing NeueHealth (NEUE) and The CompetitionMay 7, 2024 | americanbankingnews.comNeueHealth (NEUE) vs. The Competition Financial ReviewMay 7, 2024 | americanbankingnews.comNeueHealth (NEUE) versus Its Rivals Financial AnalysisMay 6, 2024 | americanbankingnews.comNeueHealth (NEUE) Scheduled to Post Quarterly Earnings on WednesdayMay 6, 2024 | americanbankingnews.comReviewing NeueHealth (NEUE) and Its PeersMay 5, 2024 | americanbankingnews.comNeueHealth (NEUE) and The Competition Head-To-Head ComparisonMay 4, 2024 | americanbankingnews.comNeueHealth (NEUE) vs. Its Competitors Head to Head ComparisonSee More Headlines Receive NEUE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeueHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/06/2024Today5/14/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryN/A Current SymbolNYSE:NEUE Previous SymbolNYSE:NEUE CUSIPN/A CIK1671284 Webwww.brighthealthgroup.com Phone612-238-1321FaxN/AEmployees1,252Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$8.00 Low Stock Price Target$8.00 Potential Upside/Downside+31.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($130.73) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,151,450,000.00 Net Margins-89.78% Pretax Margin-54.20% Return on Equity-6.14% Return on Assets2.20% Debt Debt-to-Equity RatioN/A Current Ratio0.78 Quick Ratio0.78 Sales & Book Value Annual Sales$1.11 billion Price / Sales0.05 Cash Flow$60.70 per share Price / Cash Flow0.10 Book Value($158.35) per share Price / Book-0.04Miscellaneous Outstanding Shares8,224,000Free Float2,936,000Market Cap$49.92 million OptionableN/A Beta0.78 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Robert John Sheehy (Age 66)Co-Founder & Chairman Mr. George Lawrence Mikan III (Age 52)Vice Chairman, CEO & President Comp: $3.52MMr. Jay Stephen Matushak (Age 49)Chief Financial Officer Comp: $950.28kMr. Tomas Orozco (Age 48)Executive Vice President of Consumer Care Comp: $1.14MMr. Jeffrey Joseph SchermanChief Accounting OfficerMr. Jeff Craig (Age 41)General Counsel & Corporate Secretary Comp: $582.55kMs. Stacy ContiChief People OfficerMs. Megan NorthPresident of NeueSolutionsMr. Joaquin Baralt M.D.President of Value-Based CareMore ExecutivesKey CompetitorsBright Health GroupNYSE:BHGCleneNASDAQ:CLNNOcuphire PharmaNASDAQ:OCUPDarioHealthNASDAQ:DRIOPrenetics GlobalNASDAQ:PREView All CompetitorsInsidersJay MatushakSold 317 sharesTotal: $1,917.85 ($6.05/share)Jeffrey J SchermanSold 113 sharesTotal: $683.65 ($6.05/share)George Lawrence Mikan IIISold 4,990 sharesTotal: $36,277.30 ($7.27/share)Jay MatushakSold 1,083 sharesTotal: $7,873.41 ($7.27/share)Tomas OrozcoSold 822 sharesTotal: $5,975.94 ($7.27/share)View All Insider Transactions NEUE Stock Analysis - Frequently Asked Questions Should I buy or sell NeueHealth stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NeueHealth in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NEUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NEUE, but not buy additional shares or sell existing shares. View NEUE analyst ratings or view top-rated stocks. What is NeueHealth's stock price target for 2024? 1 Wall Street research analysts have issued 1 year price objectives for NeueHealth's stock. Their NEUE share price targets range from $8.00 to $8.00. On average, they expect the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 32.2% from the stock's current price. View analysts price targets for NEUE or view top-rated stocks among Wall Street analysts. How have NEUE shares performed in 2024? NeueHealth's stock was trading at $6.53 at the beginning of 2024. Since then, NEUE shares have decreased by 7.4% and is now trading at $6.05. View the best growth stocks for 2024 here. Are investors shorting NeueHealth? NeueHealth saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 21,300 shares, a decrease of 49.5% from the April 15th total of 42,200 shares. Based on an average daily trading volume, of 11,700 shares, the short-interest ratio is currently 1.8 days. View NeueHealth's Short Interest. When is NeueHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our NEUE earnings forecast. How were NeueHealth's earnings last quarter? NeueHealth, Inc. (NYSE:NEUE) posted its quarterly earnings results on Wednesday, March, 6th. The company reported $20.07 earnings per share (EPS) for the quarter. The firm earned $292.87 million during the quarter. NeueHealth had a negative net margin of 89.78% and a negative trailing twelve-month return on equity of 6.14%. How do I buy shares of NeueHealth? Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:NEUE) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeueHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
